Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
Shoulder Innovations, Inc.NYSE: SI
Other Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other non-current liabilities remains negative
Q1 FY2026 other non-current liabilities was $0, compared with $982K a year earlier.
Context
- Other non-current liabilities amounted to 0.0% of total assets at the end of Q1 FY2026, down 1.7 pp from a year earlier.
- Other non-current liabilities increased in 1 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether other non-current liabilities keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 75.45M | +0.2% |
| FY2023 | 2023-12-31 | 75.33M | — |
Other Non-current Liabilities vs competitors
How SI compares with its peers on the latest reported figures
- SI's Mar 2026 other non-current liabilities of $0 is the 5th highest of the 11 companies compared; the peer median is $0.
- Its year-over-year change of -100.0% is the 6th highest of 7, against a peer median of +16.4%.
- Other non-current liabilities amounts to 0.0% of total assets for SI, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $21.05M | +18.4% | -31.4% | 15.9% | |
| Mar 2026 | $18.39M | +13.3% | +14.5% | 6.4% | |
| Dec 2025 | $1.16M | +67.3% | -36.6% | 0.7% | |
| Mar 2026 | $278K | +14.4% | -17.0% | 0.1% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
EPRXEupraxia Pharmaceuticals Inc. | Mar 2026 | $0 | — | — | 0.0% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | +100.0% | +53.2% | 0.0% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SI) | $0 | +16.4% | -17.0% | 0.0% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.